-
Eliquis 2021 report
Eliquis 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 30 Pages The 5 Key Questions Addressed by this Report:...
-
Xarelto 2021 report
Xarelto 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 32 Pages The 5 Key Questions Addressed by this Report:...
-
Enspryng 2020 report
Enspryng 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 17 Pages The 5 Key Questions Addressed by this Report:...
-
Prevnar 13 2020 report
Prevnar 13 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 21 Pages The 5 Key Questions Addressed by this...
-
Xeljanz 2020 report
Xeljanz 2020 U.S. PROMOTIONAL AUDIT REPORT Published July 2021 • 22 Pages The 5 Key Questions Addressed by this Report:...
-
Eliquis 2019 report
Eliquis 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 28 Pages The 5 Key Questions Addressed by this Report:...
-
Pradaxa 2019 report
Pradaxa 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 26 Pages The 5 Key Questions Addressed by this Report:...
-
Xarelto 2019 report
Xarelto 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 26 Pages The 5 Key Questions Addressed by this Report:...
-
Bevyxxa 2018 report
Bevyxxa 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 19 Pages The 5 Key Questions Addressed by this Report:...
-
Eliquis 2018 report
Eliquis 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 28 Pages The 5 Key Questions Addressed by this Report:...
-
Pradaxa 2018 report
Pradaxa 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 26 Pages The 5 Key Questions Addressed by this Report:...
-
Xarelto 2018 report
Xarelto 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 26 Pages The 5 Key Questions Addressed by this Report:...